2012 medical device industry will be supported by policy support industry plan

According to the information from the website of the China Food and Drug Administration, the 2012 National Medical Device Supervision and Management Conference was recently held in Chengdu, Sichuan. The meeting called for strengthening the construction of laws and regulations and the reform of the examination and approval mechanism. In addition, industry sources said that this year's "12th Five-Year Plan" related to medical devices will be intensively introduced.

In November last year, the Ministry of Science and Technology released the 12th Five-Year Plan for the Development of Medical Science and Technology, proposing the development of a strategic emerging industry for biopharmaceuticals with major new drugs, medical devices, and modern Chinese medicine as the core. The reporter recently learned that the key special item of the Ministry of Science and Technology “Special Plan for Scientific and Technological Development of the Medical Device Industry 2011-2015” has been completed and entered the consultation stage. The footsteps of the development are gradually approaching. In addition, after the issuance of the new version of GMP, the “12th Five-Year Plan” of the pharmaceutical packaging industry is also under development. Its main task is to increase industry concentration through joint, merger, reorganization and other means.

At the National Medical Device Supervision and Management Conference, Party Member and Deputy Director of the State Food and Drug Administration, Bi Zhenjia said that the supervision of the medical device industry will be strengthened next. He pointed out that the current supervision of medical devices is facing many problems that need to be solved urgently. For example, the regulatory system for medical devices, the supervision of infrastructure construction, and the construction of supervision teams all need to be further strengthened, and the review and approval mechanism needs to be further deepened.

Bian Zhenjia requested that in 2012, the supervision of medical devices will be promoted to a new level in three aspects. First, it is necessary to increase supervision, resolutely and severely deal with all kinds of illegal and irregular behaviors, and earnestly protect the safety of the public's machinery; Second, it is necessary to deepen The reform of the regulatory mechanism will further innovate the regulatory model and improve the overall effectiveness of medical device supervision. Third, we must pay close attention to the implementation of the work, focus on the work, grasp the key points, and take measures to ensure the effective implementation of all work goals.

According to the “2011 China Medical Device Industry Analysis and Development Prospects Forecast Report” issued by the latest Shangpu Consulting, the growth rate of the medical device market in China in 2010 was 23%, and the market size reached 120 billion yuan. It is estimated that by 2015, the entire medical equipment and equipment market in China is expected to be nearly 340 billion yuan (53.7 billion US dollars). At present, global medical devices account for 42% of the total pharmaceutical market, while China accounts for only 14% of the total pharmaceutical market, which is a huge potential.